# Case Report: A rare case of breast leiomyoma with literature review

**Authors:** Xiao Feng, Shue Zeng

PMC · DOI: 10.3389/fonc.2026.1678179 · Frontiers in Oncology · 2026-02-06

## TL;DR

This case report describes a rare benign breast tumor in a patient with a history of lymphoma, highlighting the importance of histopathology for accurate diagnosis.

## Contribution

The study adds a new case of breast leiomyoma with detailed multimodal ultrasound findings and a systematic literature review.

## Key findings

- Breast leiomyoma was confirmed histopathologically despite imaging features suggesting malignancy.
- Multimodal ultrasound features of breast leiomyoma were comprehensively documented for the first time in this case.
- Literature review identified only 11 case reports of pathologically confirmed breast leiomyoma between 2015 and 2025.

## Abstract

Breast leiomyoma is a rare benign mesenchymal tumor that typically manifests as a solitary, slow-growing mass. This article presents a case of a 58-year-old female with a history of follicular lymphoma confirmed by pathological examination of resected lymph nodes in November 2019. Follow-up positron emission tomography/computed tomography (PET-CT) revealed a breast soft-tissue mass initially classified as likely benign. Subsequent chest computed tomography (CT) in May 2024 demonstrated enlargement of the lesion, raising suspicion of lymphomatous infiltration. The mammogram shows an irregular mass shadow with shallow lobulation and scattered punctate and coarse calcification shadows. It is classified as BI-RADS 4b. Multimodal ultrasound evaluation (including grayscale ultrasound, color doppler, shear-wave elastography, strain elastography, and contrast-enhanced ultrasound) identified a solid breast mass categorized as BI-RADS 4b. Ultrasound-guided core needle biopsy revealed adenosis with focal fibroadenomatoid changes. Definitive diagnosis was achieved through surgical excision, with histopathology demonstrating fascicular arrangements of spindle-shaped smooth muscle cells on hematoxylin-eosin staining, corroborated by immunohistochemical confirmation (SMA+/desmin+). Postoperative surveillance at 6 months showed no recurrence. A search was conducted in the PubMed database using “breast leiomyoma” as the keyword, with the publication date limited to January 1, 2015, to May 3, 2025. A total of 192 articles were retrieved. After applying rigorous selection criteria, 11 case reports that met the criteria were finally included for systematic review, involving a total of 12 cases of pathologically confirmed breast leiomyoma (one report contained 2 cases). Notably, only one study comprehensively characterized the contrast-enhanced ultrasound features, and no elastography examination was performed in any of the cases. This report presents a case of breast leiomyoma in a patient with a history of lymphoma. The imaging features were highly suggestive of malignancy, yet histopathological examination confirmed a benign lesion. This study aims to analyze the clinical and preoperative imaging characteristics of this case. Combined with a comprehensive literature review, it thoroughly explores the diagnostic imaging manifestations of breast leiomyoma, providing a reference for clinical differential diagnosis.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989), follicular lymphoma (MONDO:0018906)

## Full-text entities

- **Genes:** MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}, BCL6 (BCL6 transcription repressor) [NCBI Gene 604] {aka BCL5, BCL6A, LAZ3, ZBTB27, ZNF51}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}
- **Diseases:** Breast fibroadenomas (MESH:D061325), follicular lymphoma (MESH:D008224), necrosis (MESH:D009336), lymphomatous infiltration (MESH:D013967), lymphoma (MESH:D008223), leiomyoma (MESH:D007889), breast cancer (MESH:D001943), uterine leiomyoma (OMIM:150699), calcification (MESH:D002114), Malignant (MESH:D009369), adenosis (MESH:D005348), nodule (MESH:D016606), leiomyosarcoma (MESH:D007890), fibrosis (MESH:D005355), otitis media (MESH:D010033), fibroadenoma (MESH:D018226), mesenchymal tumor (MESH:C535700)
- **Chemicals:** rituximab (MESH:D000069283), Hematoxylin (MESH:D006416), H-E (-), H&amp;E (MESH:D006371), eosin (MESH:D004801), sulfur hexafluoride (MESH:D013459), prednisone acetate (MESH:D011241), tamoxifen (MESH:D013629), cyclophosphamide (MESH:D003520)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922233/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922233/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922233/full.md

---
Source: https://tomesphere.com/paper/PMC12922233